Author Information
Marc Steven Sabatine is a distinguished researcher affiliated with the TIMI Study Group at the Division of Cardiovascular Medicine, Brigham and Women's Hospital, and Harvard Medical School in Boston, MA, USA. His work primarily focuses on cardiovascular medicine, where he has contributed significantly to the understanding and treatment of heart-related conditions.Research Contributions
Marc Steven Sabatine has made substantial contributions to cardiovascular research, particularly in understanding and improving treatment strategies for heart failure and other cardiovascular conditions. His recent works include studies on the efficacy and safety of Dapagliflozin in heart failure with reduced ejection fraction, as well as analyses of cardiovascular and renal outcomes in relation to baseline HbA1c levels. Notably, his research extends to stroke genetics and how it informs drug discovery and risk prediction across different ancestries.Aliases
Marc Steven Sabatine is also known by several aliases including Md. Marc S. Sabatine, Mark S. Sabatine, Marc S Sabatine, M. S. Sabatine, M Sabatine, Marc Sabatine, M S Sabatine, M.s. Sabatine, and Mark Sabatine. These variations might appear in various publications and references to his work.Publication and Citation Metrics
| Citation Count |
71,803 |
| H-index |
121 |
| Paper Count |
781 |
